$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer459,5286,915,896shares bought: 514,538 / shares sold: -577,957 SELLMay 31 20172 months ago
Clark Mitchall G.EVP & Chief R & QA Officer156,8732,360,939shares bought: 85,558 / shares sold: -14,080 STRONG BUYMay 17 20172 months ago
DOBMEIER ERICDirector12,500188,125shares bought: 10,000 / shares sold: 0 STRONG BUYJun 12 20171 month ago
Fust Matthew KDirector27,298410,835shares bought: 13,410 / shares sold: 0 STRONG BUYJun 12 20171 month ago
Gallagher Carol GiltnerDirector108,3741,631,029shares bought: 18,829 / shares sold: -5,735 STRONG BUYJun 12 20171 month ago
Haqq ChristopherEVP, R&D & Chief Scientific Of362,0805,449,304shares bought: 143,646 / shares sold: -76,806 STRONG BUYJul 18 20173 days ago
HEIDEN WILLIAM KDirector7,000105,350shares bought: 7,000 / shares sold: 0 STRONG BUYJun 12 20171 month ago
MARCUS JOEL SDirector7,000105,350shares bought: 7,000 / shares sold: 0 STRONG BUYJun 12 20171 month ago
MCGRATH JOHNEVP & Chief Financial Officer113,7621,712,118shares bought: 100,141 / shares sold: -66,395 BUYMay 17 20172 months ago
Porter DerrellSVP, Head of Global Commercial00May 11 20172 months ago
SEIDENBERG BETH CDirector13,689206,019shares bought: 7,000 / shares sold: 0 STRONG BUYJun 12 20171 month ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 18 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS14.926,00089,520362,080368.1 K to 362.1 K (-1.63 %)
Jun 16 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS12.656,00075,900368,080374.1 K to 368.1 K (-1.60 %)
Jun 12 2017ATRAAtara Biotherapeut ...SEIDENBERG BETH CDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...SEIDENBERG BETH CDirectorGrantA0.005,000013,6898.7 K to 13.7 K (+57.54 %)
Jun 12 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS13.151,00013,150107,374108.4 K to 107.4 K (-0.92 %)
Jun 12 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorGrantA0.005,0000108,374103.4 K to 108.4 K (+4.84 %)
Jun 12 2017ATRAAtara Biotherapeut ...MARCUS JOEL SDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...MARCUS JOEL SDirectorGrantA0.005,00007,0002 K to 7 K (+250.00 %)
Jun 12 2017ATRAAtara Biotherapeut ...HEIDEN WILLIAM KDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...HEIDEN WILLIAM KDirectorGrantA0.005,00007,0002 K to 7 K (+250.00 %)
Jun 12 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...Fust Matthew KDirectorGrantA0.005,000027,29822.3 K to 27.3 K (+22.42 %)
Jun 12 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.005,000012,5007.5 K to 12.5 K (+66.67 %)

View all Atara Biotherapeutics, Inc. insider transactions.